Status:

UNKNOWN

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Iron-Deficiency Anemia

Eligibility:

FEMALE

18-50 years

Phase:

PHASE2

Brief Summary

This study evaluates Buxue Yimu Pills,Ferrous Sulfate and the addition of Buxue Yimu Pills to Ferrous Sulfate in the treatment of Iron-Deficiency Anemia in adults women. One third of participanta will...

Detailed Description

Buxue Yimu Pills, Ferrous Sulfate each Improve anemia, but they do so by different machanisms. We generally treat patients with uncomplicated Iron Deficiency Anemia with oral iron due to the ease of a...

Eligibility Criteria

Inclusion

  • Subject is a female between the age of 18 and 50.
  • Subject suffers from mild to moderate anemia with a hemoglobin between 80g/L and 110 g/L.
  • Subject has definite gynecological etiological factors of iron deficiency
  • Subject provides written informed consent.

Exclusion

  • Subject underwent chronic digestive tract inflammation,uncontrolled digestive or urinary system bleeding.
  • Subject has other complications in addition to gynecological diseases leading to iron deficiency,such as hemorrhagic diseases of hematologic system,parasitic diseases like ancylostomiasis,chronic intravascular hemolysis,mechanical hemolysis like prosthetic valve,renal dysfunction and hemodialysis.
  • Subject is pregnant or lactating.
  • Subject has a severe systemic disease, such as cardiovascular system
  • Subject has a history of malignancy or radiotherapy.
  • Subject has undergone any Iron deficiency anemia treatment including Iron supplements or blood transfusion within 1month prior to randomization.
  • Subject has mental disorder incapable of elementary cooperations.
  • Subject has participated in other clinical researches of medicine within 1month prior to randomization.

Key Trial Info

Start Date :

June 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 28 2019

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT03232554

Start Date

June 1 2017

End Date

February 28 2019

Last Update

February 13 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lei Li

Beijing, Beijing Municipality, China, 10000